Alex and medical oncologist, Mark Scholz, MD, discuss a combination of immunotherapy, hormone therapy, and radiation for men with metastatic castrate-resistant prostate cancer. Recent research has suggested that radiation causes the "abscopal effect" in some men which may help the immune system detect and fight prostate cancer.
0:06 Is combination therapy given sequentially or all at once?
1:56 Is radiation therapy used in relapsed and advanced prostate cancer in order to stimulate an immune response?
3:32 Can any kind of radiation trigger the abscopal effect?
3:55 Does the location of the metastatic lesion affect the abscopal effect?
4:26 How will immune therapy shape the future of prostate cancer treatment?
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #Prostate #MarkScholzMD
